Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |